Most Americans consider limb amputation to be the result of a traumatic and non-avoidable event. But for the 18 million citizens who develop Peripheral Artery Disease (PAD), the possibility of a preventable limb amputation is a stark reality.
Read MoreScientists have revealed how proteins in menstrual blood can be used to stimulate skin repair, including wounds that otherwise recover poorly. Today, tens of billions of dollars are spent on chronic skin injuries, and increasing rates of diabetes are adding to this demand, so utilizing the womb’s incredible ability to repair itself quickly could be the way forward.
Read MorePhysicians should consider racial and ethnic disparities in care for patients with peripheral artery disease and not overlook opportunities to address these problems, according to a speaker at AMP: The Amputation Prevention Symposium.
Read MoreWound healing is a complex process that involves intricate interplay among multiple skin and immune cell types. When optimal conditions are achieved, wounds can heal by true regeneration, when new hairs and new adipose tissue re-form.
Read MoreNationally, rural hospitals are struggling, and Dayton General Hospital is unquestionably rural. As the centerpiece of the larger Columbia County Health System, it serves a population of approximately 4,000. Yet despite its circumstances, Dayton General is looking to the future, and that means state-of-the-art technology such as the hospital’s new hyperbaric chamber.
Read MoreAllegan General Hospital’s Wound Healing Center is bringing attention to peripheral arterial disease (PAD) in September for PAD Awareness Month. According to a press release provided by Allegan General Hospital, PAD develops when arteries become completely or partially blocked with plaque deposits that limit blood flow to legs.
Read MoreIntegra LifeSciences Holdings Corporation (Nasdaq:IART), a leading global medical technology company, today announced it has been selected as a primary provider for cellular-based tissue products within Healogics® Inc. new iSupply program.
Read MoreSolsys Medical, LLC (“Solsys”) (formerly known and doing business as Soluble Systems, LLC) (“Solsys Medical”), which markets TheraSkin®, a cellular and tissue-based product for regenerative wound healing, announced today that it has partnered with Healogics, the nations largest provider of advanced chronic wound care services, to be a part of the new Healogics iSupply program, offering TheraSkin to Healogics facilities.
Read MoreThis first of its kind program provides hospital partners with solutions to better manage total cost of care and quality outcomes related to wound care products
Read MoreThe CHI St. Luke’s Health-Memorial Wound Care Center has been named a Healogics Center of Distinction.
Read More